Blood test for early detection of colorectal cancer and adenomas
Official title: A Liquid Biopsy Assay For The Non-Invasive Early Detection of Advanced Adenomas and Colorectal Cancer
Run by City of Hope Medical Center · NCT06342440 · Data updated 2026-11-12
This study is testing a new blood test to see if it can help find early signs of colorectal cancer and adenomas in people who are already scheduled for a colonoscopy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 2000 (estimated) |
| Sponsor | City of Hope Medical Center Academic / other |
| Locations | 6 sites (Monrovia, California and 5 other locations) |
| Status | Recruiting |
| Started | March 15, 2020 |
| Main results expected | June 18, 2028 |
| Study ends | June 18, 2028 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT06342440 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are individuals who have undergone a colonoscopy and are at risk for colorectal cancer or adenomas.
✕Probably not a fit
Patients with hereditary colorectal cancer syndromes or inflammatory bowel diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to develop a highly sensitive and cost-effective blood assay for the early detection of colorectal adenomas and cancer using advanced machine learning techniques and biological analyses. Colorectal cancer is a major health concern, and traditional screening methods often miss precursor lesions like adenomas. The proposed liquid biopsy test seeks to provide a non-invasive alternative that can detect both conditions from a single blood draw, thereby improving patient compliance and resource allocation. Participants will have undergone a colonoscopy, and blood samples will be collected prior to any curative treatment.
Why it matters
Potential benefit: If successful, this test could significantly improve early detection rates of colorectal cancer and adenomas, potentially reducing mortality associated with these conditions.
How similar studies have gone: Other studies have shown promise in using liquid biopsies for cancer detection, but this specific approach targeting colorectal adenomas and cancer is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All individuals included in the study need to have had a colonoscopy at the time of blood sampling. * Received standard diagnostic and staging (as necessary) procedures as per local guidelines, and at least one sample was drawn before receiving any curative-intent treatment. * Received standard pathological and endoscopic diagnosis and assessment for cohort assignment. Exclusion Criteria: * Hereditary colorectal cancer syndromes (identified through genetic testing). * Inflammatory bowel diseases. * Lack of written informed consent.
Where it's running
-
City of Hope Medical Center
Monrovia, California, United States Recruiting -
University of California San Diego
San Diego, California, United States Recruiting -
The First Affiliated Hospital of Dalian Medical University
Dalian, China Recruiting -
IRCCS San Raffaele
Milan, Italy Recruiting -
Mie University
Mie, Japan Recruiting -
Barcelona University
Barcelona, Spain Recruiting
Study contacts
- Principal investigator: Ajay Goel, PhD — City of Hope Medical Center
- Study coordinator: Ajay Goel, PhD
- Email: AJGOEL@COH.ORG
- Phone: 6262183452
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Detecting early onset colorectal cancer using a blood test
This study is testing a new blood test that looks for specific markers to help find early signs of colorectal cancer in young adults.
-
Assessing minimal residual disease in colorectal cancer using blood tests
This study is testing if a blood test for cancer DNA can help doctors find out which colorectal cancer patients are at risk of their cancer coming back after surgery and if they need extra treatment.
-
Using a microwave device to improve colonoscopy for detecting polyps
This study is testing a new microwave device during colonoscopies to see if it can help doctors find more polyps that might be missed with regular methods.
-
Predicting recurrence in stage II/III colorectal cancer after chemotherapy
This study is trying to create a test that can help predict if people with stage II/III colorectal cancer will have their cancer come back after chemotherapy.
-
Predicting who will benefit from adjuvant chemotherapy in stage II–III colorectal cancer using tumor splicing patterns
This project tests whether a tumor splicing signature from surgical tissue can help predict which people with stage II–III colorectal cancer will benefit from adjuvant chemotherapy.
-
Meaning-Centered Therapy for Latinos for adults with advanced cancer
This study tests whether Meaning-Centered Psychotherapy for Latinos (MCP-L) can reduce anxiety and depression and improve quality of life compared with CBT in Spanish-speaking adults with advanced cancer.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.